Ertapenem Sodium Salt: Advances in Translational Resistance
2026-05-11
This thought-leadership article explores the mechanistic and strategic value of Ertapenem (sodium salt) for translational researchers probing bacterial resistance. We integrate new epidemiological findings on carbapenemase gene dynamics with actionable guidance for resistance modeling, pharmacokinetics, and assay design, while positioning APExBIO's Ertapenem sodium salt as a pivotal research tool for Gram-positive and Gram-negative bacteria.
PFOS Induces HK-2 Cell Injury via Ferroptosis and ER Stress
2026-05-10
This study reveals that perfluorooctane sulfonate (PFOS) induces cytotoxicity in human kidney (HK-2) cells through both ferroptosis and endoplasmic reticulum stress pathways. The findings clarify mechanisms underlying PFOS nephrotoxicity and highlight critical protein markers, providing a foundation for further exploration of ER stress modulation strategies in renal toxicity research.
Meropenem Trihydrate: Metabolomics-Guided Research & Resista
2026-05-09
Explore how Meropenem trihydrate empowers researchers using advanced metabolomics to dissect resistance phenotypes and optimize antibacterial strategies. This article uniquely bridges cutting-edge analytical science with practical guidance for antibiotic resistance studies.
Tetrahydromagnolol: Deciphering Peripheral CB2 Signaling Net
2026-05-09
Explore the advanced signaling mechanisms of tetrahydromagnolol, a potent peripheral CB2 receptor agonist, and its unique applications in cannabinoid receptor research. This article unveils previously underexplored assay design strategies and practical insights for targeting inflammation and metastasis.
Cholecystokinin Octapeptide Ammonium: Mechanisms & Evidence
2026-05-08
Cholecystokinin octapeptide ammonium (CCK-8 ammonium) is a potent, sulfated peptide agonist of CCK1R and CCK2R, central to modulating neurobehavioral and immune responses. Rigorous studies confirm its roles in hippocampal plasticity, apoptosis inhibition, and ANP secretion. APExBIO provides high-purity CCK-8 ammonium (C8717), enabling reproducible research across behavioral neuroscience and immunology.
Epoxomicin: Selective Proteasome Inhibitor for Research
2026-05-07
Epoxomicin is a naturally occurring, highly selective, and irreversible proteasome inhibitor widely used in ubiquitin-proteasome pathway research. Its covalent binding to the 20S proteasome’s catalytic core enables precise dissection of protein degradation and inflammatory signaling. APExBIO provides Epoxomicin (A2606) as a standardized tool for advanced cellular and disease model studies.
Surface Chemistry Drives Biocompatible Magnetic CNC Hyperthe
2026-05-07
This study systematically elucidates how the surface chemistry of cellulose nanocrystals (CNCs) affects their interaction with magnetite nanoparticles, directly impacting colloidal stability, interfacial bonding, and magnetic heating performance for hyperthermia applications. Importantly, it establishes a quantitative foundation for rationally designing biocompatible magnetic nanocomposites, with cytotoxicity assays confirming their safety for mammalian cells.
Technical Guide: FITC-Concanavalin A (ConA) Conjugate Use
2026-05-06
FITC-Concanavalin A (ConA) Conjugate enables precise, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces, facilitating workflows in immunofluorescence, flow cytometry, and glycobiology research. This reagent should only be used for carbohydrate-binding applications and within its specified storage and stability parameters. It is not suitable for non-carbohydrate workflows or for use beyond its shelf-life.
Homoharringtonine: Translational Gateways from Protein Synth
2026-05-06
Explore how the cytotoxic alkaloid Homoharringtonine bridges cancer biology and SARS-CoV-2 antiviral research. This article offers a unique translational perspective, integrating mechanistic insights with emerging assay strategies.
Technical Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling
2026-05-05
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus offers a streamlined solution for researchers needing efficient synthesis of fluorescently labeled RNA probes, specifically for applications such as in situ hybridization and Northern blotting. It is strictly intended for research use, and should not be used for diagnostic or therapeutic workflows.
GKT137831: Redefining Nox1/Nox4 Inhibition for Fibrosis and
2026-05-05
Explore the advanced mechanism and unique research applications of GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor. This in-depth analysis bridges oxidative stress control with the latest insights into lipid scrambling and ferroptosis, offering actionable guidance for fibrosis and vascular remodeling studies.
Repurposing Lopinavir: Inhibition of MERS-CoV in Cell Cultur
2026-05-04
de Wilde et al. systematically screened an FDA-approved compound library for inhibitors of Middle East respiratory syndrome coronavirus (MERS-CoV) replication. They identified four small molecules—chloroquine, chlorpromazine, loperamide, and notably lopinavir (ABT-378)—that suppressed MERS-CoV replication in vitro at low-micromolar concentrations. These findings highlight the potential of rapid drug repurposing for emerging viral threats and inform future antiviral research strategies.
Pseudo-UTP: Redefining RNA Stability for Translational Break
2026-05-04
This thought-leadership article explores the transformative role of pseudo-modified uridine triphosphate (Pseudo-UTP) in advancing mRNA synthesis, stability, and immunogenicity control for translational researchers. Integrating mechanistic insights, recent in vivo validation, and workflow strategies, it positions Pseudo-UTP as a foundation for next-generation mRNA therapeutics—especially in immuno-oncology and gene therapy—while providing strategic guidance on experimental implementation and future directions.
Selective FOXM1 Degradation Overcomes Chemoresistance in Can
2026-05-03
This study identifies STL427944, a novel small molecule that induces autophagic degradation of FOXM1, a transcription factor driving chemoresistance in multiple cancers. By using gene network analysis, the research demonstrates a selective mechanism for enhancing chemosensitivity, offering new directions for overcoming drug resistance in oncology.
ARCA Cy3 EGFP mRNA (5-moUTP): Fluorescent mRNA for Imaging a
2026-05-02
ARCA Cy3 EGFP mRNA (5-moUTP) stands out as a direct-detection, immune-evasive fluorescent mRNA ideal for tracking delivery and translation in mammalian cells. Its 5-methoxyuridine modification and Cy3 label enable high-sensitivity imaging and robust protein expression, streamlining transfection optimization and workflow reproducibility.
457 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page